Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 1,055 | 163 | 1,000 | 0 | 9,000 |
| Gross Profit | 1,055 | 163 | 1,000 | N/A | 9,000 |
| Operating Expenses | 15,335 | 15,731 | 14,727 | 14,106 | 17,108 |
| Operating Income | -14,280 | -15,568 | -13,727 | -14,106 | -8,108 |
| Other Income | 6 | 6 | 5 | 27 | 445 |
| Pre-tax Income | -14,274 | -15,563 | -13,723 | -14,079 | -7,663 |
| Net Income Continuous | -14,274 | -15,563 | -13,723 | -14,079 | -7,663 |
| Net Income | $-14,274 | $-15,563 | $-13,723 | $-14,079 | $-7,663 |
| EPS Basic Total Ops | -28.00 | -33.00 | -29.00 | -32.00 | -18.00 |
| EPS Basic Continuous Ops | -28.16 | -33.00 | -28.88 | -32.14 | -17.58 |
| EPS Diluted Total Ops | -28.00 | -33.00 | -29.00 | -32.00 | -18.00 |
| EPS Diluted Continuous Ops | -28.16 | -33.00 | -28.88 | -32.14 | -17.58 |
| EBITDA(a) | $-14,212 | $-15,500 | $-13,661 | $-14,038 | $-8,040 |